4//SEC Filing
MOULDER LEON O JR 4
Accession 0001104659-25-098413
CIK 0001953926other
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 5:24 PM ET
Size
7.5 KB
Accession
0001104659-25-098413
Insider Transaction Report
Form 4
MOULDER LEON O JR
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2025-10-07$20.85/sh+36,928$769,949→ 36,928 total(indirect: See Footnote)
Holdings
- 1,672,039(indirect: See Footnote)
Common Stock
- 266,155
Common Stock
Footnotes (3)
- [F1]On October 7, 2025, the Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008 (the "Trust"), of which the reporting person is a Trustee, entered into a Securities Purchase Agreement, dated as of October 7, 2025, by and among the Issuer and the investors party thereto, pursuant to which the Trust acquired 36,928 shares of common stock at a purchase price of $20.85 per share.
- [F2]The reporting person is a Trustee of the Trust and may be deemed to have voting and dispositive power over the shares held by the Trust. The reporting person is the Issuer's chief executive officer and Chairman of its board of directors. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- [F3]The reporting person is the Managing Member of Tellus BioVentures LLC ("Tellus") and may be deemed to have voting and dispositive power over the shares held by Tellus. The reporting person is the Issuer's chief executive officer and Chairman of its board of directors. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Zenas BioPharma, Inc.
CIK 0001953926
Entity typeother
Related Parties
1- filerCIK 0001228865
Filing Metadata
- Form type
- 4
- Filed
- Oct 8, 8:00 PM ET
- Accepted
- Oct 9, 5:24 PM ET
- Size
- 7.5 KB